SMTI Stock Summary and Trading Ideas (Sanara Medtech | NASDAQ:SMTI)

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Sanara Medtech trades on the NASDAQ stock market under the symbol SMTI.

As of April 15, 2026, SMTI stock price climbed to $20.01 with 84,977 million shares trading.

SMTI has a beta of 1.31, meaning it tends to be more sensitive to market movements. SMTI has a correlation of 0.13 to the broad based SPY ETF.

SMTI has a market cap of $183.43 million. This is considered a Micro Cap stock.

Last quarter Sanara Medtech reported $28 million in Revenue and $.09 earnings per share. This beat revenue expectation by $146,000 and missed earnings estimates by -$.02.

In the last 3 years, SMTI traded as high as $49.87 and as low as $16.05.

The top ETF exchange traded funds that SMTI belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

SMTI has underperformed the market in the last year with a return of -33.2%, while the SPY ETF gained +31.2%. In the last 3 month period, SMTI fell short of the market, returning -13.6%, while SPY returned +1.6%. However, in the most recent 2 weeks SMTI has outperformed the stock market by returning +16.5%, while SPY returned +7.6%.

SMTI support price is $17.72 and resistance is $19.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SMTI shares will trade within this expected range on the day.